Model for prediction of paced atrial activation time and interatrial conduction delay

• US 7,925,346 B1
• Filed: 01/16/2007
• Issued: 04/12/2011
• Est. Priority Date: 01/16/2007
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Go, Andre
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Kimball; Jeremiah T
• Application Number:
  US11/623,389
• Time in Patent Office: 1,547 Days
• Field of Search: 607/9, 703/6, 703/11
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3624 occurring in the atrium, i.e. atrial tachycardia
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

An exemplary device includes control logic to determine a paced atrial activation time using a predictive model and an intrinsic atrial activation time and to determine an atrioventricular delay based at least in part on the paced atrial activation time. Such a device may be an implantable device configured to deliver cardiac therapy that uses atrial pacing and ventricular pacing. Such a device may be a programmer configured to program an implantable device configured to deliver cardiac therapy that uses atrial pacing and ventricular pacing. Various other exemplary technologies are also disclosed.

Claims

1. A method of using an implantable device comprising:

acquiring right atrial activity data and left atrial activity data for intrinsic atrial activations and paced atrial activations, the data sufficient to determine intrinsic atrial activation times and paced atrial activation times;

providing a model for paced atrial activation times as a function of intrinsic atrial activation times;

fitting the model to the data;

using the model to predict a paced atrial activation time based on a subsequently determined intrinsic atrial activation time; and

using the predicted paced atrial activation time to provide pacing to an atria.

2. The method of claim 1 wherein the acquiring acquires data for a group of patients.

3. The method of claim 1 wherein the acquiring right atrial data comprises using a right atrial lead implanted in the right atrial appendage of a patient.

4. The method of claim 1 wherein the acquiring left atrial data comprises using a lead implanted at least in the coronary sinus of a patient.

5. The method of claim 1 wherein the model comprises a linear model.

6. The method of claim 1 wherein the fitting comprises a regression analysis.

7. The method of claim 1 wherein the model comprises two or more model parameters.

8. The method of claim 1 wherein the acquiring comprises acquiring rate data.

9. The method of claim 1 wherein each of atrial activation times is determined as a difference between right atrial activity data corresponding to P wave onset and left atrial activity data corresponding to a last associated event in the left atria.

10. The method of claim 1 further comprising providing a model for a difference between paced atrial activation times and intrinsic atrial activation times as a function of intrinsic atrial activation times;

and fitting the model to the data.

11. The method of claim 10 wherein the model represents the difference, defined as paced atrial activation times minus intrinsic atrial activation times, as decreasing with increasing intrinsic atrial activation times.

12. A method of using an implantable device comprising:

providing a predictive model for paced atrial waveform width as a function of intrinsic atrial waveform width, the predictive model fit to data corresponding to previously determined intrinsic atrial waveform widths and paced atrial waveform widths;

providing a subsequent intrinsic atrial waveform width;

predicting a paced atrial waveform width using the predictive model and the intrinsic atrial waveform width;

determining an atrioventricular delay based at least in part on the predicted paced atrial waveform width; and

programming an implantable device to deliver a therapy using the atrioventricular delay wherein the therapy uses atrial pacing and ventricular pacing.

13. The method of claim 12 wherein the determining an atrioventricular delay comprises determining an offset based on the paced atrial waveform width.

14. The method of claim 12 wherein the determining an atrioventricular delay comprises determining a paced interatrial conduction delay.

15. The method of claim 12 further comprising adjusting the atrioventricular delay with respect to a pacing rate.

16. The method of claim 12 wherein the predictive model comprises a linear model.

17. The method of claim 12 wherein the model comprises one or more parameters determined using a regression analysis of data acquired from a group of patients.

18. The method of claim 12 wherein the model comprises one or more parameters determined using a regression analysis of data acquired from a patient.

19. The method of claim 12 wherein the atrioventricular delay provides for adequate left ventricular filling based on the paced atrial waveform width.

20. The method of claim 12 wherein the determining an atrioventricular delay based at least in part on the paced atrial waveform width determines a ventricular pacing time that avoids premature contraction of the left ventricle.

21. The method of claim 12 wherein each of the intrinsic atrial waveform widths comprises a difference between a time based on right atrial activity and a time based on the left atrial activity and wherein each of the paced atrial waveform widths comprises a difference between a time of an atrial stimulus, or a time based on the right atrial activity, and a time based on the left atrial activity.

22. An implantable device comprising:

a pulse generator configured to provide pacing pulses to an atria so as to induce paced atrial activations;

sensing circuitry configured to sense intrinsic atrial activations and paced atrial activations; and

a processor configured to;

acquire right atrial activity data and left atrial activity data for intrinsic atrial activations and paced atrial activations,

determine intrinsic atrial activation times and paced atrial activation times from the data;

provide a model for paced atrial activation times as a function of intrinsic atrial activation times;

fit the model to the data; and

use the model to predict a paced atrial activation time based on a subsequently determined intrinsic atrial activation time.